Kapplex Inc

UPDATE (May 4, 2016): Miroculus acquires Kapplex to advance diagnostics for complex diseases (https://tiap.ca/2016/05/miroculus-acquires-kapplex-to-advance-diagnostics-for-complex-diseases/) Kapplex is a Toronto-based startup developing sensitive, high-performance and multiplexed point-of-care diagnostic platforms suitable for use in doctor’s offices, urgent care, and emergency rooms to enable clinicians to rapidly and accurately diagnose a disease at a patient’s first visit and significantly improve the course of treatment while reducing healthcare costs. The Kapplex instruments and consumables are driven by a proprietary Digital Microfluidic (DMF) platform developed in Dr. Aaron Wheeler’s lab at the University of Toronto. DMF dramatically simplifies and automates traditional sample preparations and analyses on a single, low-cost chip driven by a low-cost instrument.